PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

New drugs could stop the growth of drug-resistant childhood tumors

Scientists identify a new drug target and demonstrate its effectiveness compared to existing treatments

2015-09-15
(Press-News.org) Current drugs may stop working against the most common type of brain tumor in children, medulloblastoma, but the tumor could be targeted in a new way, according to Stanford University scientists.

In research to be published in the journal eLife, a team led by Prof. Matthew P. Scott at the University's School of Medicine tested a drug called Roflumilast in mice with a brain tumor that is resistant to Vismodegib, the drug in current use. Roflumilast is normally used to treat inflammatory lung diseases. It dramatically inhibited tumor growth from the first day of treatment. As expected, Vismodegib had no effect.

Roflumilast is already FDA-approved so it is readily available for patients. However, it also causes side effects, so further studies are needed to find ways to reduce them or to develop other drugs that avoid this problem.

"New drugs beyond Vismodegib are needed because the current treatments for medulloblastoma have severe side effects, cure only about two-thirds of patients, and leave treated patients with lasting damage," says Dr. Xuecai Ge, the first author of the study.

Some birth defects and tumors are caused by abnormalities in the way cells communicate with one another as an embryo grows. The Hedgehog signalling pathway is a cell-to-cell communication system essential for the normal growth of many tissues and organs in animal embryos.

Among other roles, Hedgehog signalling proteins stimulate the proliferation of certain type of precursor cells before they mature into neurons in the developing cerebellum - the lower rear part of the brain. When genes that encode components of the Hedgehog signalling system are damaged by mutation, cells may think they are receiving a growth-stimulating signal when they are not. This leads to loss of growth control, and contributes to a wide range of tumors, including medulloblastoma, the most common malignant brain tumor in children.

The most common human cancer, basal cell carcinoma of the skin, is also due to loss of control of Hedgehog signalling and is treatable with Vismodegib. However those tumors, like the brain tumors, can mutate further to become resistant to the drug.

Within medulloblastomas, the cancer cells mutate continuously, so even cancers that can initially be treated with Vismodegib will selectively lose sensitive cells while mutated resistant cells eventually proliferate and take over. Vismodegib targets a particular molecule in the Hedgehog signalling pathway, inhibiting cell division. In the current study, the scientists uncover an important new way in which the response to a Hedgehog signal is regulated. This could provide a new target for treatment.

They found that a protein called Semaphorin 3 enhances the response to a Hedgehog signal. Elevated levels of Semaphorin 3 have been found in medulloblastoma. They reasoned that blocking the effect of Semaphorin 3 could inhibit the response to Hedgehog and therefore cell division.

Semaphorin 3 activates an enzyme called PDE4D. By inhibiting PDE4D with a drug, Roflumilast, the scientists were able to inhibit tumor growth that had arisen from loss of control of Hedgehog signalling. Since Roflumilast affects a process that is independent of the one affected by Vismodegib, it works against Vismodegib-resistant tumors.

Roflumilast is already used to treat chronic obstructive pulmonary disease. It and other PDE4D inhibitors are also in clinical trials to improve cognitive and psychological disorders including memory loss. However, they have severe side effects, such as depression and weight loss.

"Our study shows that it is a priority to repurpose PDE4D inhibitors, perhaps in combination with other medicines, as a promising therapy for devastating and potentially fatal childhood brain tumors," says Dr. Ge.

PDE4D inhibitors could also be effective against more common cancers such as basal cell carcinoma that also arise from damage to Hedgehog signalling.

INFORMATION:



ELSE PRESS RELEASES FROM THIS DATE:

Research breakthrough in fight against muscle wasting diseases

Research breakthrough in fight against muscle wasting diseases
2015-09-15
This news release is available in French. Montreal, September 15th 2015 - It is estimated that half of all cancer patients suffer from a muscle wasting syndrome called cachexia. Cancer cachexia impairs quality of life and response to therapy, which increases morbidity and mortality of cancer patients. Currently, there is no approved treatment for muscle wasting but a new study from the Research Institute of the McGill University Health Centre (RI-MUHC) and University of Alberta could be a game changer for patients, improving both quality of life and longevity. The ...

World loses trillions of dollars worth of nature's benefits each year due to land degradation

World loses trillions of dollars worth of natures benefits each year due to land degradation
2015-09-15
To better inform the tradeoffs involved in land use choices around the world, experts have assessed the value of ecosystem services provided by land resources such as food, poverty reduction, clean water, climate and disease regulation and nutrients cycling. Their report today estimates the value of ecosystem services worldwide forfeited due to land degradation at a staggering US $6.3 trillion to $10.6 trillion annually, or the equivalent of 10-17% of global GDP. Furthermore, the problem threatens to force the migration of millions of people from affected areas. ...

New efficiency record for solar hydrogen production is 14 percent

New efficiency record for solar hydrogen production is 14 percent
2015-09-15
Solar energy is abundantly available globally, but unfortunately not constantly and not everywhere. One especially interesting solution for storing this energy is artificial photosynthesis. This is what every leaf can do, namely converting sunlight to chemical energy. That can take place with artificial systems based on semiconductors as well. These use the electrical power that sunlight creates in individual semiconductor components to split water into oxygen and hydrogen. Hydrogen possesses very high energy density, can be employed in many ways and could replace fossil ...

Researchers explore cocoa as novel dietary source for prevention of cognitive deterioration in AD

2015-09-15
Amsterdam, NL, September 9, 2015 - The potential benefits of dietary cocoa extract and/or its final product in the form of chocolate have been extensively investigated in regard to several aspects of human health. Cocoa extracts contain polyphenols, which are micronutrients that have many health benefits, including reducing age-related cognitive dysfunction and promoting healthy brain aging, among others. Dr. Giulio Maria Pasinetti, MD, PhD, Saunders Family Chair and Professor of Neurology at the Icahn School of Medicine at Mount Sinai, Director of Biomedical Training ...

MRI improves diagnosis of microbleeding after brain injury in military personnel

MRI improves diagnosis of microbleeding after brain injury in military personnel
2015-09-15
OAK BROOK, Ill. - Imaging patients soon after traumatic brain injury (TBI) occurs can lead to better (more accurate) detection of cerebral microhemorrhages, or microbleeding on the brain, according to a study of military service members, published online in the journal Radiology. Cerebral microhemorrhages occur as a direct result of TBI and can lead to severe secondary injuries such as brain swelling or stroke. The ability to monitor the evolution of microhemorrhages could provide important information regarding disease progression or recovery. According to the Centers ...

Effects of prenatal myelomeningocele closure on the need for a CSF shunt

2015-09-15
CHARLOTTESVILLE, VA (SEPTEMBER 15, 2015). Management of Myelomeningocele Study (MOMS) investigators analyzed updated data on the effects of prenatal myelomeningocele closure on the need for placement of a cerebrospinal fluid (CSF) shunt within the first 12 months of life. These researchers reaffirm the initial MOMS finding that prenatal repair of a myelomeningocele results in less need for a shunt at 12 months and introduce the new finding that prenatal repair reduces the need for shunt revision in those infants who do require shunt placement. The researchers also found ...

Link between air pollution, increased deaths and increased deaths from heart disease affirmed

2015-09-15
In what is believed to be the largest, most detailed study of its kind in the United States, scientists at NYU Langone Medical Center and elsewhere have confirmed that tiny chemical particles in the air we breathe are linked to an overall increase in risk of death. The researchers say this kind of air pollution involves particles so small they are invisible to the human eye (at less than one ten-thousandth of an inch in diameter, or no more than 2.5 micrometers across). In a report on the findings, published in the journal Environmental Health Perspectives online Sept. ...

'Our chairs are killing us,' say researchers

2015-09-15
Amsterdam, The Netherlands, September 15, 2015 -- Prolonged sitting time as well as reduced physical activity contribute to the prevalence of non-alcoholic fatty liver disease (NAFLD) in a study of middle-aged Koreans. These findings support the importance of both reducing time spent sitting and increasing physical activity, say researchers. Their results are published in the Journal of Hepatology. Physical activity is known to reduce the incidence and mortality of various chronic diseases. However, more than one half of the average person's waking day involves sedentary ...

Combining epigenetic therapies with immunotherapies likely to improve cancer patient outcomes

2015-09-15
PHILADELPHIA -- Recent data suggest that epigenetic therapies are likely to provide additional clinical benefit to cancer patients when rationally combined with immunotherapeutic drugs, according to a review published in Clinical Cancer Research, a journal of the American Association for Cancer Research. "The term epigenetics refers to the study of cellular changes in gene expression that are heritably transmitted during cell replication," said Michele Maio, MD, PhD, chair of medical oncology and immunotherapy, Ospedale Santa Maria alle Scotte, Istituto Toscano Tumori, ...

Video game warnings fall far short in rating tobacco content

2015-09-15
Video games are not adequately rated for tobacco content, according to a new UC San Francisco study that found video gamers are being widely exposed to tobacco imagery. The researchers concluded that a national ratings board set up more than 20 years ago is not a reliable source for learning whether video games contain tobacco imagery. The study will be published online September 14 in Tobacco Control. "Parents should stop relying on the ratings to screen for tobacco use in buying video games for their kids," said first author Susan Forsyth, a PhD candidate at ...

LAST 30 PRESS RELEASES:

Eighty-five years of big tree history available in one place for the first time

MIT invents human brain model with six major cell types to enable personalized disease research, drug discovery

Health and economic air quality co-benefits of stringent climate policies

How immune cells deliver their deadly cargo

How the brain becomes a better listener: How focus enhances sound processing

Processed fats found in margarines unlikely to affect heart health

Scientists discover how leukemia cells evade treatment

Sandra Shi MD, MPH, named 2025 STAT Wunderkind

Treating liver disease with microscopic nanoparticles

Chemicals might be hitching a ride on nanoplastics to enter your skin

Pregnant patients with preexisting high cholesterol may have elevated CV risk

UC stroke experts discuss current and future use of AI tools in research and treatment

The Southern Ocean’s low-salinity water locked away CO2 for decades, but...

OHSU researchers develop functional eggs from human skin cells

Most users cannot identify AI bias, even in training data

Hurricane outages: Analysis details the where, and who, of increased future power cuts

Craters on surface of melanoma cells found to serve as sites for tumor killing

Research Spotlight: Mapping overlooked challenges in stroke recovery

Geographic and temporal patterns of screening for breast, cervical, and colorectal cancer in the US

Cannabis laws and opioid use among commercially insured patients with cancer diagnoses

Research Spotlight: Surprising gene mutation in brain’s immune cells linked to increased Alzheimer’s risk

Missing molecule may explain Down syndrome

Donor diabetes and 1-year Descemet membrane endothelial keratoplasty success rate

Endothelial cell loss 1 year after successful DMEK in the diabetes endothelial keratoplasty study

Overactive Runx1 gene triggers early disc degeneration linked to aging

NYU Langone Health chair of ophthalmology, Dr. Kathryn Colby, honored with Castroviejo Medal at AAO 2025

Chemotherapy combination boosts overall survival in patients with EGFR-mutant non-small cell lung cancer

FAU’s Queen Conch Lab receives prestigious international award

Post-traumatic vasospasm: An overlooked threat after brain injury

Scientists smash record in stacking semiconductor transistors for large-area electronics

[Press-News.org] New drugs could stop the growth of drug-resistant childhood tumors
Scientists identify a new drug target and demonstrate its effectiveness compared to existing treatments